NCT07350850: A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

Sponsor: Tongji Hospital. Phase: PHASE2. Conditions: PCNSL, Primary Central Nervous System Lymphoma